Cargando…

HTLV-1 intragenic viral enhancer influences immortalization phenotype in vitro, but is dispensable for persistence and disease development in animal models

Human T-cell leukemia virus type 1 (HTLV-1) is the causative infectious agent of adult T-cell leukemia/lymphoma (ATL) and chronic neurological disease. The disparity between silenced sense transcription versus constitutively active antisense (Hbz) transcription from the integrated provirus is not fu...

Descripción completa

Detalles Bibliográficos
Autores principales: Maksimova, Victoria, Smith, Susan, Seth, Jaideep, Phelps, Cameron, Niewiesk, Stefan, Satou, Yorifumi, Green, Patrick L., Panfil, Amanda R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359075/
https://www.ncbi.nlm.nih.gov/pubmed/35958554
http://dx.doi.org/10.3389/fimmu.2022.954077
_version_ 1784764060897640448
author Maksimova, Victoria
Smith, Susan
Seth, Jaideep
Phelps, Cameron
Niewiesk, Stefan
Satou, Yorifumi
Green, Patrick L.
Panfil, Amanda R.
author_facet Maksimova, Victoria
Smith, Susan
Seth, Jaideep
Phelps, Cameron
Niewiesk, Stefan
Satou, Yorifumi
Green, Patrick L.
Panfil, Amanda R.
author_sort Maksimova, Victoria
collection PubMed
description Human T-cell leukemia virus type 1 (HTLV-1) is the causative infectious agent of adult T-cell leukemia/lymphoma (ATL) and chronic neurological disease. The disparity between silenced sense transcription versus constitutively active antisense (Hbz) transcription from the integrated provirus is not fully understood. The presence of an internal viral enhancer has recently been discovered in the Tax gene near the 3’ long terminal repeat (LTR) of HTLV-1. In vitro, this enhancer has been shown to bind SRF and ELK-1 host transcription factors, maintain chromatin openness and viral gene transcription, and induce aberrant host gene transcription near viral integration sites. However, the function of the viral enhancer in the context of early HTLV-1 infection events remains unknown. In this study, we generated a mutant Enhancer virus (mEnhancer) and evaluated its effects on HTLV-1-mediated in vitro immortalization, establishment of persistent infection with an in vivo rabbit model, and disease development in a humanized immune system (HIS) mouse model. The mEnhancer virus was able to establish persistent infection in rabbits, and there were no significant differences in proviral load or HTLV-1-specific antibody responses over a 25-week study. However, rabbits infected with the mEnhancer virus had significantly decreased sense and antisense viral gene expression at 12-weeks post-infection. HIS mice infected with wt or mEnhancer virus showed similar disease progression, proviral load, and viral gene expression. While mEnhancer virus was able to sufficiently immortalize primary T-lymphocytes in cell culture, the immortalized cells had an altered phenotype (CD8(+) T-cells), decreased proviral load, decreased sense and anti-sense gene expression, and altered cell cycle progression compared to HTLV-1.wt immortalized cells (CD4(+) T-cells). These results suggest that the HTLV-1 enhancer element alone does not determine persistence or disease development but plays a pivotal role in regulating viral gene expression.
format Online
Article
Text
id pubmed-9359075
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93590752022-08-10 HTLV-1 intragenic viral enhancer influences immortalization phenotype in vitro, but is dispensable for persistence and disease development in animal models Maksimova, Victoria Smith, Susan Seth, Jaideep Phelps, Cameron Niewiesk, Stefan Satou, Yorifumi Green, Patrick L. Panfil, Amanda R. Front Immunol Immunology Human T-cell leukemia virus type 1 (HTLV-1) is the causative infectious agent of adult T-cell leukemia/lymphoma (ATL) and chronic neurological disease. The disparity between silenced sense transcription versus constitutively active antisense (Hbz) transcription from the integrated provirus is not fully understood. The presence of an internal viral enhancer has recently been discovered in the Tax gene near the 3’ long terminal repeat (LTR) of HTLV-1. In vitro, this enhancer has been shown to bind SRF and ELK-1 host transcription factors, maintain chromatin openness and viral gene transcription, and induce aberrant host gene transcription near viral integration sites. However, the function of the viral enhancer in the context of early HTLV-1 infection events remains unknown. In this study, we generated a mutant Enhancer virus (mEnhancer) and evaluated its effects on HTLV-1-mediated in vitro immortalization, establishment of persistent infection with an in vivo rabbit model, and disease development in a humanized immune system (HIS) mouse model. The mEnhancer virus was able to establish persistent infection in rabbits, and there were no significant differences in proviral load or HTLV-1-specific antibody responses over a 25-week study. However, rabbits infected with the mEnhancer virus had significantly decreased sense and antisense viral gene expression at 12-weeks post-infection. HIS mice infected with wt or mEnhancer virus showed similar disease progression, proviral load, and viral gene expression. While mEnhancer virus was able to sufficiently immortalize primary T-lymphocytes in cell culture, the immortalized cells had an altered phenotype (CD8(+) T-cells), decreased proviral load, decreased sense and anti-sense gene expression, and altered cell cycle progression compared to HTLV-1.wt immortalized cells (CD4(+) T-cells). These results suggest that the HTLV-1 enhancer element alone does not determine persistence or disease development but plays a pivotal role in regulating viral gene expression. Frontiers Media S.A. 2022-07-25 /pmc/articles/PMC9359075/ /pubmed/35958554 http://dx.doi.org/10.3389/fimmu.2022.954077 Text en Copyright © 2022 Maksimova, Smith, Seth, Phelps, Niewiesk, Satou, Green and Panfil https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Maksimova, Victoria
Smith, Susan
Seth, Jaideep
Phelps, Cameron
Niewiesk, Stefan
Satou, Yorifumi
Green, Patrick L.
Panfil, Amanda R.
HTLV-1 intragenic viral enhancer influences immortalization phenotype in vitro, but is dispensable for persistence and disease development in animal models
title HTLV-1 intragenic viral enhancer influences immortalization phenotype in vitro, but is dispensable for persistence and disease development in animal models
title_full HTLV-1 intragenic viral enhancer influences immortalization phenotype in vitro, but is dispensable for persistence and disease development in animal models
title_fullStr HTLV-1 intragenic viral enhancer influences immortalization phenotype in vitro, but is dispensable for persistence and disease development in animal models
title_full_unstemmed HTLV-1 intragenic viral enhancer influences immortalization phenotype in vitro, but is dispensable for persistence and disease development in animal models
title_short HTLV-1 intragenic viral enhancer influences immortalization phenotype in vitro, but is dispensable for persistence and disease development in animal models
title_sort htlv-1 intragenic viral enhancer influences immortalization phenotype in vitro, but is dispensable for persistence and disease development in animal models
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359075/
https://www.ncbi.nlm.nih.gov/pubmed/35958554
http://dx.doi.org/10.3389/fimmu.2022.954077
work_keys_str_mv AT maksimovavictoria htlv1intragenicviralenhancerinfluencesimmortalizationphenotypeinvitrobutisdispensableforpersistenceanddiseasedevelopmentinanimalmodels
AT smithsusan htlv1intragenicviralenhancerinfluencesimmortalizationphenotypeinvitrobutisdispensableforpersistenceanddiseasedevelopmentinanimalmodels
AT sethjaideep htlv1intragenicviralenhancerinfluencesimmortalizationphenotypeinvitrobutisdispensableforpersistenceanddiseasedevelopmentinanimalmodels
AT phelpscameron htlv1intragenicviralenhancerinfluencesimmortalizationphenotypeinvitrobutisdispensableforpersistenceanddiseasedevelopmentinanimalmodels
AT niewieskstefan htlv1intragenicviralenhancerinfluencesimmortalizationphenotypeinvitrobutisdispensableforpersistenceanddiseasedevelopmentinanimalmodels
AT satouyorifumi htlv1intragenicviralenhancerinfluencesimmortalizationphenotypeinvitrobutisdispensableforpersistenceanddiseasedevelopmentinanimalmodels
AT greenpatrickl htlv1intragenicviralenhancerinfluencesimmortalizationphenotypeinvitrobutisdispensableforpersistenceanddiseasedevelopmentinanimalmodels
AT panfilamandar htlv1intragenicviralenhancerinfluencesimmortalizationphenotypeinvitrobutisdispensableforpersistenceanddiseasedevelopmentinanimalmodels